A Universal Strategy of Anti‐Tumor mRNA Vaccine by Harnessing “Off‐the‐Shelf” Immunity
Abstract Personalized neoantigen cancer mRNA vaccines are promising candidates for precision medicine. However, the difficulty of identifying neoantigens heavily hinders their broad applicability. This study developed a universal strategy of anti‐tumor mRNA vaccine by harnessing “off‐the‐shelf” immu...
Saved in:
| Main Authors: | Jiayan Fu, Shuangqi Wu, Nengcheng Bao, Lili Wu, Huiru Qu, Zhechao Wang, Haiyang Dong, Jian Wu, Yongfeng Jin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-02-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202401287 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harnessing mRNA vaccines for viral diseases: bottleneck and breakthrough
by: Vijay Mishra, et al.
Published: (2025-08-01) -
Research progress of mRNA vaccines for infectious diseases
by: Zhen Zhang, et al.
Published: (2025-08-01) -
Unraveling the potential: mRNA therapeutics in oncology
by: Karol Gawalski, et al.
Published: (2025-08-01) -
Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications
by: Kai Yuan Leong, et al.
Published: (2025-03-01) -
mRNA turnover rate limits siRNA and microRNA efficacy
by: Erik Larsson, et al.
Published: (2010-11-01)